Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Biodesix, Inc.    BDSX

BIODESIX, INC.

(BDSX)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
01/11/2021 01/12/2021 01/13/2021 01/14/2021 01/15/2021 Date
22.55(c) 22.31(c) 23.78(c) 25.99(c) 28(c) Last
101 017 103 415 95 455 64 767 259 487 Volume
+6.42% -1.06% +6.59% +9.29% +7.73% Change
More quotes
Financials (USD)
Sales 2020 33,5 M - -
Net income 2020 -33,8 M - -
Net cash position 2020 47,4 M - -
P/E ratio 2020 -22,0x
Yield 2020 -
Sales 2021 73,0 M - -
Net income 2021 -10,9 M - -
Net cash position 2021 15,6 M - -
P/E ratio 2021 -69,4x
Yield 2021 -
Capitalization 743 M 743 M -
EV / Sales 2020 20,8x
EV / Sales 2021 9,97x
Nbr of Employees 186
Free-Float -
More Financials
All news about BIODESIX, INC.
01/13HIBERCELL : and Biodesix Initiate Broad Collaboration for Companion Diagnostic D..
PR
01/08BIODESIX : Projects Record Q4 Revenue of Up to $27 Million
MT
01/08BIODESIX INC : Results of Operations and Financial Condition, Regulation FD Disc..
AQ
01/08BIODESIX : Anticipates Strong Preliminary Fourth Quarter 2020 Revenue (unaudited..
BU
01/06BIODESIX : Working With Purdue University to Offer Rapid Antigen COVID-19 Tests ..
MT
01/06BIODESIX : Purdue Partners With Colorado Company to Offer Rapid Testing for Stud..
BU
01/05BIODESIX INC : Change in Directors or Principal Officers, Regulation FD Disclosu..
AQ
01/05BIODESIX : Names Ryan Siurek as Chief Accounting Officer
MT
2020BIODESIX : Starts Biomarker Study to Assess Nodify XL2 Test's Performance in Lun..
MT
2020BIODESIX : Initiates Biomarker Study to Affirm Nodify XL2® Test's Importance in ..
BU
2020BIODESIX : Study Shows Proprietary Device Collects, Separates, and Transports Bl..
BU
2020BIODESIX : Reports Narrower Q3 Loss, Higher Revenue
MT
2020BIODESIX : Announces Third Quarter 2020 Results and Provides Corporate Update
BU
2020BIODESIX : Management's Discussion and Analysis of Financial Condition and Resul..
AQ
2020BIODESIX INC : Results of Operations and Financial Condition, Financial Statemen..
AQ
More news
News in other languages on BIODESIX, INC.

- No features available -

More news
Analyst Recommendations on BIODESIX, INC.
More recommendations
Chart BIODESIX, INC.
Duration : Period :
Biodesix, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BIODESIX, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Average target price 23,00 $
Last Close Price 28,00 $
Spread / Highest target -3,57%
Spread / Average Target -17,9%
Spread / Lowest Target -28,6%
EPS Revisions
Managers and Directors
NameTitle
Scott Hutton President, Chief Executive Officer & Director
John Patience Chairman
Robin Harper Cowie Chief Financial Officer, Secretary & Treasurer
James R. Jett Co-Chief Medical Officer
Steven C. Springmeyer Co-Chief Medical Officer